Menu
Development of methodology for prioritisation in cancer screening/prevention
Summary
This task will entail activities organised within the following
subtasks:
4.4.1 Situation analysis of prioritisation in cancer screening.
4.4.2 Development of a framework for prioritisation of cancer screening programs.
4.4.3 Pilot testing of prioritisation framework in exemplary countries to assess the feasibility, acceptability and comprehensibility of the prioritisation framework.
4.4.4 Validation and transferability of the MAS-AI tool for AI assessment in healthcare and expansion of the tool to novel screening based on the EUnetHTA core model, specifically to evaluate AI interventions.
This task will be led by EMC, Netherlands, co-led by CPO Turin, Italy; CSF, Finland; and RSYD, Denmark.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
